Commentary: infliximab or adalimumab in Crohn's disease?

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2012-08, Vol.36 (4), p.398-398
Main Authors: Sprakes, M. B., Hamlin, P. J.
Format: Article
Language:English
Subjects:
Anti-Inflammatory Agents - therapeutic use
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized - therapeutic use
Crohn Disease - drug therapy
Female
Humans
Male
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0269-2813
1365-2036
DOI:10.1111/j.1365-2036.2012.05167.x